Institutional Research Collaboration between the Liverpool School of Tropical Medicine and the Centers for Disease Control and Prevention | Apply Online

Frequently Asked Questions (FAQs)

What is the title and funding opportunity number for this grant?

The opportunity is titled "Institutional Research Collaboration between the Liverpool School of Tropical Medicine and the Centers for Disease Control and Prevention." The Funding Opportunity Number is GH15 006 SUPP 16.

What type of funding opportunity is this?

This is a CDC discretionary cooperative agreement. A cooperative agreement generally indicates that the CDC expects to have substantial involvement in the work, beyond providing funds.

What is the primary purpose of this cooperative agreement?

The core aim is to strengthen malaria-focused public health work through applied research and program evaluation. The opportunity supports operational research, surveillance enhancements, and monitoring and evaluation (M&E) activities intended to produce practical, high-impact findings.

Is this opportunity focused on basic science research?

The emphasis is not on basic science alone. The opportunity is oriented toward real-world program questions and on-the-ground evidence that can directly improve malaria control strategies and outcomes.

What kinds of projects does the CDC Malaria Branch want to fund under this opportunity?

The CDC Malaria Branch is seeking innovative research projects and evaluation activities that can generate actionable insights or strategies to reduce malaria burden and improve population health and well-being in malaria-endemic settings.

What are examples of the types of activities mentioned as a fit for this funding?

Activities highlighted in the description include studies of how interventions perform under routine implementation conditions, efforts to strengthen malaria surveillance systems for timely and accurate decision-making, and work to improve how programs measure results through monitoring and evaluation.

What does "operational research" mean in the context of this opportunity?

Based on the description provided, operational research here refers to applied studies that address practical program questions, particularly questions that arise during real-world implementation of malaria control strategies, and that can produce findings usable by programs in the field.

What is the role of surveillance enhancements in this opportunity?

The opportunity explicitly includes surveillance enhancements, with an emphasis on improving the ability of malaria surveillance systems to support timely and accurate decision-making in malaria-endemic settings.

What is the role of monitoring and evaluation (M&E) in this opportunity?

M&E is a central focus area. The description emphasizes improving how malaria programs measure results and assess effectiveness, supporting stronger accountability and better program performance.

Where are the funded activities expected to take place?

The geographic emphasis is on sub-Saharan Africa and Asia, reflecting regions where malaria burden and program scale-up needs are often greatest, and where improvements in surveillance and evaluation can have significant public health impact.

How is this opportunity connected to the Roll Back Malaria (RBM) initiative?

The opportunity is framed within the CDC Malaria Branch's role as a partner in the Roll Back Malaria (RBM) initiative. The announcement indicates that funded activities should contribute to RBM-aligned objectives, including coordinated international efforts, capacity reinforcement, and improved accountability and effectiveness of malaria programs.

What does the cooperative agreement mechanism imply about CDC involvement?

It signals that CDC expects substantial involvement in the work. The description notes involvement typically through collaboration on project design, technical guidance, and alignment with broader public health priorities.

When was this opportunity posted and created?

The opportunity was posted and created on December 21, 2015.

What was the application closing date?

The application closing date was February 23, 2016.

How many awards were expected to be made?

The opportunity indicated one expected award.

What is the CFDA number associated with this opportunity?

The CFDA number listed is 93.326.

What is the maximum funding amount (award ceiling) for this grant?

The award ceiling is listed as 0 in the summary data. This typically indicates that a specific maximum funding amount was not stated in the summary information provided, and that the full announcement text would normally need to be consulted for budget expectations, allowable costs, and constraints.

Who is eligible to apply?

Eligibility is listed broadly as "Others." The information provided notes that further clarification is contained in an "Additional Information on Eligibility" section in the full opportunity documentation, suggesting eligibility may be limited to certain institutions or partners consistent with the named collaboration focus.

Does the description indicate any specific institutional collaboration?

Yes. The title explicitly references an institutional research collaboration between the Liverpool School of Tropical Medicine and the Centers for Disease Control and Prevention.

What is the overall public health goal of the funded work?

The overall goal is to reduce the malaria burden and improve population health and well-being in malaria-endemic settings by generating practical evidence and actionable strategies through applied research, surveillance improvements, and evaluation.